131
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Investigation and Analysis of the Colonization and Prevalence of Carbapenem-Resistant Enterobacteriaceae in Pediatric Liver Transplant Recipients

, , , , , , & show all
Pages 1957-1966 | Published online: 25 May 2021

References

  • Zhang J, Yu W, Zhao LN, et al. Epidemiology and characteristics of antibacterial resistance in China. Chin J Clin Infect Dis. 2016;9(2):118–128.
  • Zhang Y, Zeng J, Liu W, et al. Emergence of a hypervirulent carbapenem—resistant Klebsiella pneumoniae isolate from clinical infections in China. J Infect. 2015;71(5):553–560. doi:10.1016/j.jinf.2015.07.01026304687
  • Lu WT. The Prevalence and Resistance Mechanism of Carbapenem–Resistance Gram-Negative Bacilli in Stool Specimens from Patients. Guangzhou: SouthernMedical University; 2015.
  • Mazza E, Prosperi M, Panzeri MF, et al. Carbapenem-resistant Klebsiella pneumoniae infections early after liver transplantation: a single-center experience. Transplant Proc. 2017;49(4):677–681. doi:10.1016/j.transproceed.2017.02.02828457370
  • Giannella M, Bartoletti M, Morelli MC, et al. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization. Am J Transplant. 2015;15:1708–1715. doi:10.1111/ajt.1313625754742
  • Pereira MR, Scully BF, Pouch SM, et al. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumonia infections in liver transplant recipients. Liver Transpl. 2015;21:1511–1519. doi:10.1002/lt.2420726136397
  • Freire MP, Oshiro IC, Pierrotti LC, et al. Carbapenem-resistant Enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation. 2017;101:811–820. doi:10.1097/TP.000000000000162028009779
  • Shen YH, Fan J, Zhou J, et al. Pulmonary infection and its risk factors after orthotopic liver transplantation. Chin J Liver Dis. 2007;15(11):833–836.
  • Li H, Gu Y, Xing TH, et al. Characterization and homology analysis of the multidrug-resistant gram-negative bacteria isolated from liver transplant recipients. Chin J Infect Chemother. 2011;11(6):457–462.
  • Huang X, Deng Z, Yuxin N, et al. Chinese experts’ consensus on prevention and control of multidrug resistance organism healthcare-associated infection. Chin J Infect Control. 2015;14(1):1–9.
  • Temkin E, Adler A, Lerner A, et al. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management. Ann N Y Acad Sci. 2014;1323(1):22–42. doi:10.1111/nyas.1253725195939
  • Kritikos A, Manuel O. Bloodstream infections after solid-organ transplantation. Virulence. 2016;7:329–340. doi:10.1080/21505594.2016.113927926766415
  • Geladari A, Karampatakis T, Antachopoulos C, et al. Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department. Transpl Infect Dis. 2017;19:1–10.
  • Freire MP, Villela soares oshiro IC, Bonazzi PR, et al. Surveillance culture for multidrug-resistant gram-negative bacteria: performance in liver transplant recipients. Am J Infect Control. 2017;45(3):e40–e44. doi:10.1016/j.ajic.2016.12.01028254253
  • Chen W, Yang T, Liu WL. The clinical application of fecal microbiota transplantation. Electron Ed Chin Organ Transplant J. 2018;12(1):42–48.
  • Dinh A, Fessi H, Duran C, et al. Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study. J Hosp Infect. 2018;99:481–486. doi:10.1016/j.jhin.2018.02.01829477634
  • Lee JJ, Yong D, Suk KT, et al. Alteration of gut microbiota in carbapenem-resistant Enterobacteriaceae carriers during fecal microbiota transplantation according to decolonization periods. Microorganisms. 2021;9(2):352. doi:10.3390/microorganisms902035233578974
  • Davido B, Batista R, Dinh A, et al. Fifty shades of graft: how to improve the efficacy of faecal microbiota transplantation for decolonization of antibiotic-resistant bacteria. Int J Antimicrob Agents. 2019;53(5):553–556. doi:10.1016/j.ijantimicag.2019.03.00830880228
  • Dai M, Liu Y, Chen W, et al. Rescue fecal microbiota transplantation for antibiotic-associated diarrhea in critically ill patients. Crit Care. 2019;23(1):324. doi:10.1186/s13054-019-2604-531639033
  • Marcella C, Cui B, Kelly C, et al. In systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Aliment Pharmacol Ther. 2021;53(1):33–42. doi:10.1111/apt.1614833159374